Practical support for physical health, condition-specific, patient-support, prevention, rehabilitation and community-health organisations that need more resilient income while protecting access, evidence, patient trust and care quality.
Take the Revenue Diversification ScorecardHealth charities often sit between communities, patients, carers, clinicians, researchers, employers and an NHS under sustained pressure. They may hold deep expertise, trusted relationships and proven services, yet still depend on a narrow mix of donations, grants, NHS or local-authority contracts and time-limited partnerships.
The pressure is not theoretical. Many health charities are managing rising demand and delivery costs while public-service funding and commissioning remain constrained. A contract may increase turnover without covering the full cost of delivery. An employer or commercial partnership may create income, but only if it protects independence and public trust. Valuable patient insight can inform better services and research, but it must never be treated as a commodity.
This makes diversification more than a search for new funding. The task is to identify who genuinely benefits from the organisation's expertise, who should pay, what must remain free to patients and communities, and which opportunities the team can deliver without weakening core services.
The first step is not launching a new offer. It is deciding which opportunities are sufficiently valuable, ethical and viable to test.
For health and wellbeing organisations, revenue clarity means understanding:
This is the difference between adding another underfunded activity and building a credible, mission-aligned revenue model.
Resilient income rarely comes from replacing grants or NHS funding with one commercial offer. It comes from building a balanced portfolio around work the organisation already does well.
That may include commissioned prevention or community services, professional education, employer health programmes, licensed tools, research and patient-insight services, membership or accreditation, strategic corporate partnerships, or mission-linked trading.
The payer does not have to be the beneficiary. In candidate models to assess, patients and communities continue to receive free support while employers, commissioners, professionals, institutions or commercial partners pay for a distinct form of value.
The discipline lies in choosing routes that strengthen the mission, recover their true costs and can be delivered consistently.
Candidate commercial routes generally come from making trusted expertise and proven delivery more usable for a specific buyer to test.
Package specialist knowledge into training, continuing professional development, train-the-trainer programmes or implementation support for health professionals, schools, employers, public bodies and voluntary-sector partners.
Explore clearly costed propositions around outreach, rehabilitation, social prescribing, health coaching, navigation, or long-term-condition support, backed by explicit clinical governance, qualified supervision, and incident reporting where clinical activities are delivered.
Test demand from employers seeking to respond to specific health conditions through manager training, workplace guidance, return-to-work support, and inclusive policies, validating actual commercial willingness to pay.
Charge institutions for properly governed recruitment, facilitation, accessibility, and co-design administration for universities and life-sciences partners, while distinguishing public involvement from research and ensuring contributors receive fair recognition and compensation.
Assess turning validated tools, curricula, assessment frameworks, digital resources, delivery models or standards into licensed products, organisational membership, accreditation or implementation packages where market demand and assurance capacity exist.
Move beyond general sponsorship into partnerships with a clear exchange of value, such as specialist education, advisory collaboration, campaign licensing, staff engagement or mission-linked retail and events.
Revenue for Impact helps health and wellbeing organisations move from broad pressure - 'we need more unrestricted income' - to a clearer view of which opportunities have genuine buyer value, fit the mission and can be delivered sustainably.
The approach helps teams map their assets, expertise, evidence and relationships; compare possible buyers and income models; test mission fit and capacity; understand full delivery costs; and select one focused route for validation.
For this sector, the value is not generic commercialisation. It is a disciplined route from trusted expertise to a well-governed, properly costed offer that can strengthen rather than subsidise the mission.
Select the level of support that matches your current stage of planning.
Take the Revenue Diversification Scorecard to identify where your organisation may already have credible income potential and where further clarity is needed.
The Free Revenue Diversification Blueprint introduces a structured way to move from broad income pressure to a focused opportunity map.
The Premium Revenue Diversification Blueprint is an interactive toolkit that helps you map opportunities, assess mission fit and viability, model pricing, use structured AI prompts and build a focused 90-day pilot plan.
The Revenue Opportunity Snapshot provides a tailored report identifying three potential revenue pathways, their likely buyers, setup complexity and a practical first test. It includes lifetime access to the Premium Blueprint.
Clear answers to common questions about health and wellbeing revenue diversification.
No. Many credible models keep essential support free while commissioners, employers, professionals, research organisations or commercial partners pay for a distinct service, resource or outcome. The payer and beneficiary do not have to be the same.
They can form part of a resilient portfolio, but only when the specification, price, payment terms and contract length support full delivery costs. A restricted contract that requires charitable subsidy may increase activity while weakening financial resilience.
Organisations do not sell patient experience itself. They may charge institutions for properly governed recruitment, facilitation, accessibility, administration and co-design support, while ensuring participants give informed consent, retain their agency and receive fair recognition or compensation.
Often practical starting points to test are narrow and focused: condition-specific manager training, professional education, a validated toolkit, implementation support, co-design facilitation or a commissioned community service. The aim is to test one focused proposition, not build an entire commercial division at once.